CA2458279A1 - Modulation of vitamin storage - Google Patents
Modulation of vitamin storage Download PDFInfo
- Publication number
- CA2458279A1 CA2458279A1 CA002458279A CA2458279A CA2458279A1 CA 2458279 A1 CA2458279 A1 CA 2458279A1 CA 002458279 A CA002458279 A CA 002458279A CA 2458279 A CA2458279 A CA 2458279A CA 2458279 A1 CA2458279 A1 CA 2458279A1
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- tocopherol
- phosphate derivative
- phosphate
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/AU2001/001206 WO2002026238A1 (en) | 2000-09-26 | 2001-09-26 | Phosphate derivative supplements |
AUPCT/AU01/01206 | 2001-09-26 | ||
AU2002951045 | 2002-08-27 | ||
AU2002951045A AU2002951045A0 (en) | 2002-08-27 | 2002-08-27 | Method of supplementing nascent endogenous storage forms |
PCT/AU2002/001321 WO2003026673A1 (en) | 2001-09-26 | 2002-09-26 | Modulation of vitamin storage |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2458279A1 true CA2458279A1 (en) | 2003-04-03 |
Family
ID=25613914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002458279A Abandoned CA2458279A1 (en) | 2001-09-26 | 2002-09-26 | Modulation of vitamin storage |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1429782A4 (de) |
JP (1) | JP2005515969A (de) |
CA (1) | CA2458279A1 (de) |
MX (1) | MXPA04001779A (de) |
WO (1) | WO2003026673A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
MXPA05007278A (es) * | 2003-01-17 | 2005-09-30 | Vital Health Sciences Pty Ltd | Compuestos que tienen propiedades anti-proliferativas. |
JP4847437B2 (ja) * | 2004-03-03 | 2011-12-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | アルカロイド製剤 |
RU2377019C2 (ru) * | 2004-08-03 | 2009-12-27 | Вайтал Хэлф Сайнсис Пти Лтд | Транспортирующий наполнитель для энтерального применения |
CA2599612A1 (en) * | 2005-03-03 | 2006-09-08 | Vital Health Sciences Pty Ltd. | Use of phosphate derivatives of electron transfer agents for lowering increased circulating blood levels of a lipid |
KR20070108382A (ko) * | 2005-03-03 | 2007-11-09 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 항암성 화합물 |
MX2007015949A (es) | 2005-06-17 | 2008-03-07 | Vital Health Sciences Pty Ltd | Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos. |
NZ601528A (en) * | 2010-02-05 | 2015-04-24 | Phosphagenics Ltd | A low solvent carrier composition for delivery of biologically active compounds |
AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
RU2553350C2 (ru) | 2010-03-30 | 2015-06-10 | Фосфейдженикс Лимитед | Трансдермальные пластыри |
WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
EP3383371B1 (de) | 2015-12-09 | 2024-05-01 | Avecho Biotechnology Limited | Pharmazeutische formulierung |
JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2854631B2 (ja) * | 1989-11-21 | 1999-02-03 | 千寿製薬株式会社 | 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤 |
US5114957A (en) * | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
FR2679904A1 (fr) * | 1991-08-01 | 1993-02-05 | Lvmh Rech | Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues. |
US5643597A (en) * | 1991-08-01 | 1997-07-01 | Lvmh Recherche | Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
AU3662093A (en) * | 1992-02-14 | 1993-09-03 | Robert Lamb | Phosphate derivatives of vitamin e to protect cells from effects of aging and injury |
JPH05286848A (ja) * | 1992-04-10 | 1993-11-02 | Senju Pharmaceut Co Ltd | 浴用剤 |
FR2715565B1 (fr) * | 1994-01-31 | 1996-03-15 | Oreal | Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation. |
JP3362501B2 (ja) * | 1994-04-28 | 2003-01-07 | 千寿製薬株式会社 | 角膜障害治療剤 |
JPH10155429A (ja) * | 1996-11-27 | 1998-06-16 | Showa Denko Kk | 動物に対するビタミンe供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物 |
JPH1143436A (ja) * | 1997-07-25 | 1999-02-16 | Showa Denko Kk | 末梢血流障害予防・治療剤 |
US5776915A (en) * | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
JP3950216B2 (ja) * | 1997-12-26 | 2007-07-25 | 日本メナード化粧品株式会社 | 皮膚外用剤 |
WO2002026238A1 (en) * | 2000-09-26 | 2002-04-04 | Vital Health Sciences Pty Ltd. | Phosphate derivative supplements |
-
2002
- 2002-09-26 JP JP2003530308A patent/JP2005515969A/ja active Pending
- 2002-09-26 CA CA002458279A patent/CA2458279A1/en not_active Abandoned
- 2002-09-26 EP EP02799356A patent/EP1429782A4/de not_active Ceased
- 2002-09-26 WO PCT/AU2002/001321 patent/WO2003026673A1/en not_active Application Discontinuation
- 2002-09-26 MX MXPA04001779A patent/MXPA04001779A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005515969A (ja) | 2005-06-02 |
MXPA04001779A (es) | 2004-05-31 |
WO2003026673A1 (en) | 2003-04-03 |
EP1429782A4 (de) | 2005-02-02 |
EP1429782A1 (de) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040241225A1 (en) | Modulation of vitamin storage | |
US5198432A (en) | Method of preventing chlorohydrocarbon toxicity using sterol derivatives | |
US8173145B2 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
US9789127B2 (en) | N-acyl-phosphatidyl-ethanolamines and/or mixtures of N-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids | |
CA2458279A1 (en) | Modulation of vitamin storage | |
US20090186856A1 (en) | Micronutrient phosphates as dietary and health supplements | |
Gross et al. | Seven day oral supplementation with Cardax TM (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats | |
JP2010241818A (ja) | 電子移動剤のホスフェート誘導体を含有する処方 | |
US5610180A (en) | Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents | |
WO2005099739A1 (en) | Oxygenated dibenzo-alpha-pyrone chromoproteins | |
Khan et al. | Phospholipids: a novel adjuvant in herbal drug delivery systems | |
AU2002333019B2 (en) | Modulation of vitamin storage | |
ZA200401126B (en) | Modulation of vitamin storage. | |
AU2002333019A1 (en) | Modulation of vitamin storage | |
US7033612B2 (en) | Composition and method for treating age-related disorders | |
CA1117041A (fr) | Complexe lipoproteique normalisant l'efficacite de la vitamine e et des antioxydants de synthese | |
AU2002322163B2 (en) | Micronutrient phosphates as dietary and health supplements | |
CH635749A5 (en) | Lipoprotein complex which regularises the efficacy of vitamin E and synthetic antioxidants | |
AU2002214820A1 (en) | Formulation containing phosphate derivatives of electron transfer agents | |
AU2002322163A1 (en) | Micronutrient phosphates as dietary and health supplements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20080926 |